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ABSTRACT
Secretory aspartyl proteinases (Saps) of Candida albicans are key virulence traits which cause
inﬂammasome-dependent, aseptic inﬂammation in a mouse model of vaginitis. In this paper,
neutrophil migration in response to Sap2, Sap6 and chemo-attractive products released from Sap-
treated vaginal epithelium was measured in vitro, ex vivo and in vivo. Our results show that Sap2 and
Sap6 induce neutrophil migration and production of potent chemoattractive chemokines such as
IL-8 and MIP-2 by vaginal epithelial cells. Our data suggest that at least part of MIP-2 production
depends upon IL-1b activity. The vaginal ﬂuid of Candida-infected mice contained a heat-labile
inhibitor of neutrophil candidacidal activity that was absent from the vaginal ﬂuid of Sap-treated
mice. Overall, our data provide additional information on the capacity of C. albicans Saps to cause
aseptic vaginal inﬂammation and highlight the potential role of some chemokines released from
vaginal epithelial cells in this phenomenon.
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Introduction
Extracellular proteolytic activity by secretory aspartyl
proteinases (Saps) has long been suggested as important
virulence trait of the pathogenic yeast Candida albicans.
C. albicans utilizes Saps, a family of 10 proteins,1 as
active enzymes to favor adherence to, and damage of,
epithelial cells. Saps secretion is also associated with
hyphal formation and immune-escape activities.2,3
The role of Saps in disease has been extensively
studied for mucosal infections, particularly vaginal
candidiasis.4 Recent data suggest that Saps are able to
trigger a pathogenic inﬂammatory immune response
likely occurring through activation of the NLRP3
inﬂammasome and that this inﬂammation is the criti-
cal determinant of vaginal candidiasis.5-7 Neutrophils
are actively recruited into the vaginal cavity during
Sap-induced inﬂammatory response,6 suggesting that
Saps have direct neutrophil chemotactic activity.
Moreover, recent data suggest a non-protective role
for neutrophils during vaginal infection that might
even exacerbate disease in humans.8
Expanding on initial observations in different disease
models,9,10 here we veriﬁed that 2 Saps, Sap2 and Sap6,
could induce neutrophil migration in in vitro, ex vivo
and in vivo mouse model of Sap-induced vaginitis with-
out infection (aseptic vaginitis). Moreover, a possible
mechanism of immune-pathogenesis of vaginal candidi-
asis was hypothesized.
Results and discussion
Because some C. albicans Saps can cause a massive neutro-
phil inﬂux, in particular into the mouse vagina,6 we ﬁrstly
analyzed whether 2 selected Saps (Sap2 and Sap6) can act
as chemoattractants for human neutrophils in vitro. IL-8
was used as positive control in these experiments. We
focused on Sap2 and Sap6, which are well-studied mem-
bers of the Sap1-3 and Sap4-6 sub-families,4 to follow-up
our previous work where we showed that Sap2 and Sap6
were more consistent than other used Saps in inducing
monocyte inﬂammatory responses in vitro 11,12 and vaginal
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inﬂammation in a mouse model.6 Nevertheless, data from
different experimental models using a C. albicans sap9D
mutant, suggested that Sap9 is required for the induction
of neutrophil chemotaxis toward C. albicans ﬁlaments.10
Dose-dependent analysis showed that a concentration
of around 0.5 mg/ml was optimal for both Saps to stimu-
late human neutrophil migration (not shown). This dose
was therefore used for all experiments. To verify if enzy-
matic activity was necessary for the chemotactic effect,
Sap2 and Sap6 were pre-incubated in the presence or
absence of Pepstatin A at a dose of 1 mg/ml, that was pre-
viously shown to strongly inhibit Sap activity.6 An enzy-
matically-inactive recombinant Sap2 (tSap2 6) was also
used to provide further evidence that Sap2-induced
migration did not require enzymatic activity. Sap2 and
Sap6 were direct chemoattractants in vitro and their
enzymatic activity was not necessary for Saps-induced
migration (Fig. 1A, left). Next, vaginal epithelium was
left unstimulated or was stimulated for 24 h with IL-8,
Sap2 or Sap6, in the presence or absence of Pepstatin A.
Then, neutrophil migration was monitored. Results in
Figure 1A (right) show that vaginal epithelium, stimu-
lated with IL-8, Sap2 or Sap6, had a signiﬁcant potential
for neutrophil chemotactic activity. Saps-induced neu-
trophil migration was signiﬁcantly higher as compared
to experiments in the absence of epithelial cells. Pretreat-
ment of Saps with Pepstatin A signiﬁcantly reduced, but
did not abolish the neutrophil migration. In line with
previous evidence of vaginal inﬂammation in the mouse
model6 the differences from data above, obtained in the
presence or absence of epithelium, are likely indicative of
the need of Sap enzymatic activity to favor Saps entering
the epithelial cells and activate the cytokine-chemokine
response (see below). This additional internal activation
adds to the direct external stimulation by Saps, which
does not require enzymatic activity.
Experiments were then done to detect chemo-attrac-
tive products released from the epithelial cells upon Sap
stimulation. We focused on well known chemokines
such as IL-8 and MIP-2.
We found that Sap2- or Sap6-stimulated vaginal epi-
thelium produced consistent amounts of MIP-2, a
known strong chemotactic factor. Sap pretreatment with
Pepstatin A signiﬁcantly reduced, but did not abolish,
MIP-2 production. IL-8, whole Candida cells or LPS plus
ATP were used as positive controls (Fig. 1B).
Since the inﬂammasome activation in Sap2-stimu-
lated vaginal epithelium leads to IL-1b production 6 and
MIP-2 secretion is enhanced by several inﬂammatory
stimuli, including IL-1b,13 we wondered whether IL-1b
could play a role in MIP-2 production. Results in
Figure 1C showed that the blockade of IL-1b receptor by
using Anakinra signiﬁcantly inhibited Sap-induced MIP-
2 production by vaginal epithelium. Anakinra also inhib-
ited Candida cell-stimulated chemokine production
(Fig. 1C) and this is in agreement with our previous
Figure 1. Effect of Saps on neutrophil migration and on MIP-2 production. Human ﬂuorescent neutrophils were incubated for 2 h to the
upper compartment of transwell ﬁlters containing Medium, IL-8 (100 ng/ml), Sap2, tSap2 or Sap6 (all 0.5 mg/ml) in the presence or
absence of Pepstatin A (1 mg/ml) (A, left) or vaginal epithelium, stimulated for 24 h in the presence or absence (Medium) of IL-8
(100 ng/ml), Sap2, tSap2 or Sap6 (all 0.5 mg/ml), pretreated or not with Pepstatin A (1 mg/ml) (A, right), in the lower compartment. The
number of migrating neutrophils into the lower compartment was measured by using ﬂuorescence signal. Data are expressed as ﬂuo-
rescence intensity of migrated neutrophils (triplicates samples of 5 different experiments, mean § SEM). Human MIP-2 was assessed on
cultures supernatants of vaginal epithelium stimulated for 24 h in the presence or absence (Medium) of IL-8 (100 ng/ml), C. albicans
(CA-6) (1 £ 107/ml), LPS (10 mg/ml) plus ATP (5 mM), Sap2 or Sap6 (both 0.5 mg/ml), pretreated or not with Pepstatin A (1 mg/ml), by
speciﬁc Elisa assay (triplicates samples of 5 different experiments, mean § SEM) (B). Human MIP-2 was also assessed on cultures super-
natants of vaginal epithelium unstimulated (Medium) or stimulated for 24 h with C. albicans (CA-6) (1 £ 107/ml), Sap2 or Sap6 (both
0.5mg/ml) in the presence or absence of Anakinra (10 mM) by speciﬁc Elisa assay (triplicates samples of 3 different experiments, mean
§ SEM) (C). , p < 0.05 IL-8, CA-6, LPS plus ATP or Saps treated vs Medium treated. #, p < 0.05 Saps C Pepstatin A treated vs Saps
treated. # #, p < 0.05 CA-6 or Saps C Anakinra treated vs CA-6 or Saps treated.
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results that the blockade of IL-1b receptor inhibited the
neutrophil inﬂux in Candida-infected mouse vagina.6
While these studies show a likely role of IL-1b and Sap-
induced production of chemokines for neutrophil migra-
tion, further studies are needed to obtain more direct
insight into this phenomenon.
To investigate the in vivo signiﬁcance of our ﬁndings,
we used our mouse model of Sap-induced vaginitis with-
out infection, that closely mimics the vaginal inﬂamma-
tion induced by the fungus.6 Vaginal washes, obtained
from mice vaginally injected with Saline, LPS, Sap2 or
Sap6, were used as potential chemoattractants. The
migration of neutrophils is shown in Figure 2A and B.
Maximal migration was induced by vaginal washes
obtained from mice injected with Sap2, but a signiﬁcant
migration was also induced by vaginal washes of mice
injected with Sap6 or LPS. Moreover, we tested whether
classical chemoattractants such as IL-8 or MIP-2 were
induced by Sap- or LPS-exposed mouse vaginal epithelial
cells and thus can contribute to neutrophil chemotaxis.
Figure 2. Neutrophil inﬂux and activity during vaginal candidiasis. Human ﬂuorescent neutrophils were incubated for 2 h to the upper
compartment of transwell ﬁlters containing, in the lower compartment, vaginal washes of mice injected for 24 h with Saline, LPS
(50 mg/10 ml/mouse), Sap2 or Sap6 (both 0.5 mg/10 ml/mouse). The number of migrating neutrophils into the lower compartment was
measured by using ﬂuorescence signal. Data are expressed as ﬂuorescence intensity of migrated neutrophils (triplicates samples of 3 dif-
ferent experiments, mean § SEM) (A). Vaginal washes of mice injected as above described were centrifuged, cellular fraction was micro-
scopically analyzed to evaluate neutrophil recruitment (arrow) (representative images of 3 separate experiments with similar results,
magniﬁcation 10 x, Bar D 50 mm) (B) or the % of double positive CD326C/IL-8C cells (triplicates samples of 3 different experiments,
mean § SEM) (C) and supernatants were collected and tested for mouse IL-8 (D) and mouse MIP-2 (E) production by speciﬁc Elisa assays
(triplicates samples of 3 different experiments, mean § SEM). Killing activity against C. albicans of human neutrophils mixed with
Medium or vaginal washes of mice injected for 24 h with Saline, Sap2 or Sap6 (both 0.5 mg/10 ml/mouse), C. albicans (CA-6) (2 £ 107/
10ml/mouse) or H. I. vaginal washes of mice injected for 24 h with C. albicans (CA-6) (2 £ 107/10ml/mouse) was shown (triplicates sam-
ples of 5 different experiments, mean § SEM) (F). , p < 0.05 LPS or Saps treated vs Saline treated mice. #, differences between LPS,
Sap2 or Sap6 treated animals resulted not signiﬁcant. y, p < 0.05 CA-6 treated vs Medium treated mice.
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As shown in Figure 2C, a cytoﬂuorimetric analysis
revealed a signiﬁcant increase of intracellular IL-8 in vag-
inal epithelial cells of mice treated with Sap2 or Sap6.
Moreover, IL-8 (Fig. 2D) and MIP-2 (Fig. 2E) were pro-
duced in vaginal ﬂuid of mice treated with Sap2 or Sap6.
MIP-2 production was signiﬁcantly decreased (by
73.6%) in vaginal ﬂuid of mice intravaginally injected
with Sap2 in the presence of anti-Sap2 Fab capable of
binding Sap2 and inhibiting its enzymatic activity. These
results closely correlate with a marked inhibition (by
85.5%) of neutrophil recruitment in the same vaginal
ﬂuid. Treatment with Pepstatin A had the same inhibi-
tory effect as the Fab in decreasing Sap2-induced MIP-2
production and neutrophil inﬂux (by 74.4% and 82.7%,
respectively). The speciﬁcity of these effects was evi-
denced by the inability of Fab and Pepstatin A to inhibit
LPS-induced MIP-2 production and neutrophil inﬂux
(not shown).
Our recent ﬁndings showed that puriﬁed Saps and C.
albicans cells are able to activate caspase-1 in murine vagi-
nal epithelial cells leading to IL-1b production and that
blockade of the IL-1b receptor caused a strong inhibition
of neutrophil inﬂux.6 Moreover, other research groups
have shown that MIP-2 secretion by epithelial cells is
enhanced by IL-1b.13 Hence, the high level of MIP-2 in
vaginal washes of Sap-exposed mice could be ascribed, at
least in part, to the elevated levels of Sap-induced IL-1b.
It has been suggested that neutrophils, which mas-
sively inﬁltrate the epithelial tissues during candidal vagi-
nitis, do not play a protective role, but are rather the
cause of the disease.14 Since neutrophils are very efﬁca-
cious Candida killers15 it is possible that vaginal neutro-
phils have reduced anti-Candida activities due to factors
released by the vaginal tissues or Candida cells during
infection. Thus, we examined whether cell-free vaginal
ﬂuids from Saps or Candida exposed vaginal epithelial
tissue could modulate the anticandidal activity of neutro-
phils. Neutrophils were mixed with medium or vaginal
washes obtained from mice injected with Saline, Sap2,
Sap6 or C. albicans cells or were left untreated. Next, the
killing activity was monitored. Results in Figure 2F show
that neutrophils alone display the expected remarkable
candidacidal activity, that was not signiﬁcantly changed
when neutrophils were mixed with vaginal washes
obtained from mice injected with Saline, Sap2 or Sap6.
On the other end, the candidacidal activity was signiﬁ-
cantly impaired when neutrophils were mixed with vagi-
nal washes obtained from mice injected with C. albicans
cells (Fig. 2F), suggesting that soluble factor(s), able to
dampen neutrophil candidacidal activity, were released
during vaginal Candida infection. These soluble factors
were not found during Sap-induced inﬂammation.
When neutrophils were mixed with heat inactivated (H.
I.) vaginal washes obtained from C. albicans-injected
mice, the killing activity was restored. Besides being
heat-labile, we have no precise data about the nature of
this factor(s). Notably, hyphae-associated glycoproteins
of C. albicans have already been reported to be inhibitory
for neutrophils functions 16 with, however, no proof they
are active in vaginal candidiasis. In addition, the inhibi-
tor could well be of host origin.
Concluding remarks
Previous studies have shown that Saps contribute to an
inﬂammatory mucosal response by the activation of IL-
1b.6 Also on the basis of observations made in other
models 9,10 we predicted that Saps may have a role in the
induction of chemoattractive cytokines. Our results
clearly indicate that: i) Saps directly induce neutrophil
migration independently on their enzymatic activity in
an in vitro experimental model; ii) even higher migration
is obtained in the presence of epithelial cells. In this case,
the surplus of Sap-induction requires enzymatic activity,
coherently with previous in vivo data.6 This is possibly
due to the need of degrading ectocellular proteinaceous
material in order to gain intracellular access, as discussed
elsewhere 6; iii) Saps induce production of MIP-2 and
IL-8 by vaginal epithelium. These potent chemokines
could therefore mediate or contribute together with
other factors to Sap-induced chemotaxis in vivo; iv) Saps
do not modulate the candidacidal activity of neutrophils.
However, we observed here that candidacidal activity of
neutrophils can be inhibited by other factors produced
by C. albicans cells or by the host during experimental
vaginal infection. While this last observation warrants a
future speciﬁc investigation, our present data further
highlight the crucial role of Sap-induced local inﬂamma-
tion during vaginal candidiasis and suggest that an anti-
Sap based therapy may help to control fungal virulence
and excess inﬂammation during this common type of
mucosal infection. They also provide a preliminary
glimpse about the mechanism of immune-pathogenesis
of vaginal candidiasis: the release of Saps during vaginal
C. albicans infection triggers the recruitment of neutro-
phils whose activity may not control the infection
because of the presence of inhibitors released by Candida
itself or the host.
Materials and methods
Aspartyl proteinases and Fab format monoclonal
antibody (mAb) production
Endotoxin-free recombinant C. albicans aspartyl protei-
nases 2 and 6 (Sap2 and Sap6) were expressed as
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recombinant proteins using, respectively, Escherichia coli
BL21 (pLysS) or Pichia pastoris clones as previously
described.6,17 An E. coli recombinant truncated Sap2
(tSap2 preparation) has been previously described.6 Fab
format of mAb capable of binding Sap2 and strongly
inhibiting its enzymatic activity was produced by AbD-
Serotec (Germany) as previously described.6
Candida albicans strain
Candida albicans strain (CA-6) used in this study has
previously been described.18
Ethic statement
Blood samples were collected from subjects after obtain-
ing informed consent, in accordance with the Declara-
tion of Helsinki, and approval was obtained from the
ethical review board.
All animal experiments were performed in agreement
with the EU Directive 2010/63 and the National Law
116/92. The protocol was approved by Perugia Univer-
sity Ethics Committee (permit number 149/2009-B). All
animals were housed in the animal facility of the Univer-
sity of Perugia (Authorization number 34/2003A).
Preparation of polymorphonuclear cells
Human peripheral blood neutrophils, obtained from
healthy donors, were separated by density gradient cen-
trifugation on Ficoll-Hypaque (Euroclone, Milan, Italy),
followed by the hypotonic lysis of erythrocytes. Neutro-
phils were then washed twice with phosphate buffered
saline (PBS) (Sigma Aldrich) and then resuspended in
5 ml RPMI-1640 without phenol red (BioWhittaker,
Walkersville, MD) containing 10% heat-treated fetal calf
serum (RPMI-FCS). Calcein AM, ﬂuorescent cell perme-
able derivative of calcein (Sigma Aldrich) (5 mg/ml) was
added to the 5 ml suspension of cells in RPMI-FCS and
the cells were incubated for 30 min at 37C plus 5%
CO2. Neutrophils were washed twice with PBS, counted
and resuspended in RPMI-FCS at 5 £ 106/ml.19
Vaginal epithelium
Human vaginal epithelium was obtained as previously
described.20
Vaginal washes
Female CD1 mice (Envigo, Milan, Italy) were purchased
at 4 to 5 weeks of age and maintained under pseudoes-
trus condition by subcutaneous (s. c.) injection of 0.2 mg
of estradiol valerate in 100 ml of sesame oil (both from
Sigma-Aldrich) 2 d prior to infection. Mice, anaesthe-
tized with 2.5–3.5 (v/v) isoﬂuorane gas, were injected
into the vaginal lumen with Saline, LPS (50 mg/10 ml/
mouse) (Sigma Aldrich), Sap2 or Sap6 (both 0.5 mg/
10 ml/mouse) or C. albicans (2 £ 107/10 ml/mouse). In
selected experiments, mice, under pseudoestrus condi-
tion, were injected 30 min before and again 30 min after
treatment with LPS (50 mg/10 ml/mouse) or Sap2
(0.5 mg/10 ml/mouse) with anti-Sap2 Fab (0.36 ng/10 ml/
mouse) or Pepstatin A (1 mg/10 ml/mouse). Twenty four
h post-infection, the vaginal lumen was thoroughly
washed with 150 ml of Saline, given in three separate 50
ml volumes.6 The washes were centrifuged at 3000 rpm
for 5 min, the supernatants were collected and centri-
fuged at 3000 rpm for 5 min. Cell-free supernatants were
tested for modulation of neutrophil killing activity and
migration, IL-8 and MIP-2 production by speciﬁc Elisa
assays (BMASSAY, BeiJing, China; RayBiotech, Nor-
cross, GA,respectively).
Fluorescence-based determination of neutrophil
migration and cytokine production
Human neutrophil migration was measured by a 96-well
chemotaxis chamber with 3.2 mm in diameter yielding a
ﬁlter with membrane porosity of 5 mm (Neuro Probe).
Fluorescent neutrophils (5 £ 106/ml) were transferred
into ChemoTx ﬁlters placed in 96-well plates containing
medium, recombinant IL-8 (100 ng/ml) (ImmunoTools
GmbH, Germany), tSap2, Sap2 or Sap6 (all 0.5 mg/ml)
pretreated or not with Pepstatin A (1 mg/ml) (Sigma
Aldrich) for 30 min at 37C plus 5% CO2. Vaginal
washes from mice treated as above described or vaginal
epithelium, stimulated for 24 h at 37C plus 5% CO2 in
the presence or absence (medium) of IL-8 (100 ng/ml),
tSap2, Sap2 or Sap6 (all 0.5 mg/ml), pretreated or not
with Pepstatin A (1 mg/ml) (Sigma Aldrich) for 30 min
at 37C plus 5% CO2, were also used as chemoattrac-
tants. The chamber was incubated for 2 h at 37C plus
5% CO2. After incubation, the non-migrating cells on
the origin side (top) of the ﬁlter were removed by gently
wiping the ﬁlter and the cells that are migrated into the
bottom chamber were measured by using ﬂuorescence
signal (excitation, 485 nm; emission, 530 nm).
For human MIP-2 production, vaginal epithelium was
also stimulated for 24 h at 37C plus 5% CO2 in the pres-
ence or absence (medium) of IL-8 (100 ng/ml), C. albi-
cans (1 £ 107/ml), LPS (10 mg/ml) plus ATP (5 mM),
Sap2 or Sap6 (both 0.5 mg/ml), pretreated or not with
Pepstatin A (1 mg/ml) (Sigma Aldrich) for 30 min at
37C plus 5% CO2. Human MIP-2 production was also
tested in supernatants of vaginal epithelium
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unstimulated (medium) or stimulated for 24 h at 37C
plus 5% CO2 with C. albicans (1 £ 107/ml), Sap2 or Sap6
(both 0.5 mg/ml) in the presence or absence of an antag-
onist of IL-1b receptor: Anakinra, (10 mM).6 Human
MIP-2 production was evaluated by speciﬁc Elisa assay
(abcam, Cambridge, UK).
Flow cytometry analysis
Total cellular fractions obtained from vaginal washes
were ﬁxed with 1.5% formalin for 10 min at room
temperature (RT), washed and incubated with
APC-labeled mAb to mouse CD326, expressed on
epithelial cells, (rat IgG2b,kisotype; 0.05 mg/tube;
eBioscience) for 20 min at RT in the dark. After
incubation, cells were washed twice with ﬂuorescent
buffer (FB), permeabilized with absolute methanol
(500 ml/106 cells) for 10 min on ice and incubated
with puriﬁed mAb to IL-8 (rabbit IgG isotype; dilution
1/250; GeneTex Inc., CA) for 20 min at RT followed
by Cy3-labeled conjugated afﬁnity puriﬁed secondary
Ab (dilution 1/100; Chemicon Int., Temecula, CA). In
selected experiments, ﬁxed total cellular fraction,
obtained from vaginal washes, were stained with
FITC-conjugated mAb to mouse Ly-6G (GR-1) (rat
IgG2b,k isotype; 0.05 mg/tube; eBioscience) per 20 min
at RT in the dark. After incubation, cells were washed
with FB and resuspended in 0.5 ml of FB. Cells were
then analyzed by ﬂow cytometry using FACSCalibur
(BD Biosciences). Autoﬂuorescence was assessed by
using untreated cells. Data are expressed as percentage
of double positive cells. Control staining of cells with
irrelevant Abs was used to obtain background ﬂuores-
cence values.
Microscopical analysis
Vaginal samples of mice injected as above described were
centrifuged by cytospin (700 rpm for 7 min), stained
with Haemacolor stain and examined by light micros-
copy (Olympus). The scale bars are in mm.
Killing activity
Human neutrophils (1 £ 105/50 ml) were mixed with
50 ml of medium or 50 ml of vaginal washes of mice
injected with Saline, Sap2, Sap6, C. albicans cells, or H. I.
(for 30 min at 60C) vaginal washes of mice injected
with C. albicans, then incubated with C. albicans (1 £
104/100 ml) for 2 h at 37C plus 5 % CO2. After incuba-
tion, killing activity was evaluated as previously
described.21
Statistical analysis
The results reported in the bar graphs are the mean §
SEM from triplicate samples of 3–5 different experi-
ments. Quantitative variables were tested for normal dis-
tribution and compared by means of Student’s t test. A
value of p < 0.05 was considered signiﬁcant.
Abbreviations
Sap Secretory aspartyl proteinase
ATP adenosine triphosphate
H. I. heat inactivated.
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